These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 22035432

  • 1. TNF inhibitors for rheumatoid arthritis - a year in review.
    Simsek I.
    Bull NYU Hosp Jt Dis; 2011; 69(3):220-4. PubMed ID: 22035432
    [Abstract] [Full Text] [Related]

  • 2. TNF inhibitors - new and old agents for rheumatoid arthritis.
    Simsek I.
    Bull NYU Hosp Jt Dis; 2010; 68(3):204-10. PubMed ID: 20969553
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis.
    Tanaka Y.
    Curr Opin Rheumatol; 2012 May; 24(3):319-26. PubMed ID: 22388646
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study.
    Lee SJ, Chang H, Yazici Y, Greenberg JD, Kremer JM, Kavanaugh A.
    J Rheumatol; 2009 Aug; 36(8):1611-7. PubMed ID: 19369454
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
    Kapetanovic MC, Roseman C, Jönsson G, Truedsson L, Saxne T, Geborek P.
    Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study.
    Genevay S, Finckh A, Ciurea A, Chamot AM, Kyburz D, Gabay C, Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis.
    Arthritis Rheum; 2007 May 15; 57(4):679-85. PubMed ID: 17471545
    [Abstract] [Full Text] [Related]

  • 17. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F, Murdaca G, Ghio M, Indiveri F.
    Autoimmun Rev; 2005 Nov 15; 4(8):537-41. PubMed ID: 16214092
    [Abstract] [Full Text] [Related]

  • 18. TNF alpha as a therapeutic target in rheumatoid arthritis.
    Feldmann M, Brennan FM, Elliott M, Katsikis P, Maini RN.
    Circ Shock; 1994 Aug 15; 43(4):179-84. PubMed ID: 7895323
    [Abstract] [Full Text] [Related]

  • 19. Comparative overview of safety of the biologics in rheumatoid arthritis.
    Khraishi M.
    J Rheumatol Suppl; 2009 Jun 15; 82():25-32. PubMed ID: 19509327
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-alpha therapy.
    Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Llorca J.
    Ann N Y Acad Sci; 2010 Apr 15; 1193():153-9. PubMed ID: 20398022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.